BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Innova Biosciences Receives Investment to Increase Sales Activities


10/1/2009 2:03:42 PM

Innova Biosciences (Cambridge, UK), a pioneer in the field of antibody labeling and inventor of the World’s easiest to use antibody labeling kit- Lightning-Link™, is pleased to announce a further cash investment into the business. Recently appointed Board member, Tim Bernard (formally Managing Director of AbD Serotec and CEO of Pivotal Scientific) has invested an undisclosed sum in the company. The new funds will be used to strengthen Innova’s sales and marketing activities.

Commenting on the investment Tim Bernard mentioned – ‘Shortly after the joining the Board, it became apparent that the company had an innovative product portfolio with a large customer base. Based upon my own experiences, such opportunities rarely come along and therefore I decided to invest in the business. I look forward to working with the Innova team to successfully grow the company.’

Dr Nick Gee, CEO of Innova Biosciences - ‘We are delighted to accept Tim’s investment, which will allow Innova to expand its sales and marketing operations and to build on the impressive growth achieved so far in 2009.’

About the company: Innova Biosciences is a growing, dynamic business, based in Cambridge, UK. At the core of Innova’s business is the Lightning-Link™, an innovative technology that simplifies antibody labeling for use in R&D applications, drug discovery and diagnostics. The expanding Lightning-Link™ portfolio currently consists of 44 individual products and is sold to research laboratories in over 30 countries around the world.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES